One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
about
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
One-month assessment of renal ...... ion-free and overall survival.
@en
One-month assessment of renal ...... ion-free and overall survival.
@nl
type
label
One-month assessment of renal ...... ion-free and overall survival.
@en
One-month assessment of renal ...... ion-free and overall survival.
@nl
prefLabel
One-month assessment of renal ...... ion-free and overall survival.
@en
One-month assessment of renal ...... ion-free and overall survival.
@nl
P2093
P2860
P1476
One-month assessment of renal ...... ion-free and overall survival.
@en
P2093
Daiki Ueno
Hiroji Uemura
Hiroki Ito
Hisashi Hasumi
Jun-Ichi Teranishi
Kazuhide Makiyama
Kazuhiro Namura
Kazuki Kobayashi
Keiichi Kondo
Kimito Osaka
P2860
P2888
P304
P356
10.1007/S00280-017-3275-Z
P577
2017-03-22T00:00:00Z